Experimental Validation of MHC Class I and II Peptide-Based Potential Vaccine Candidates for Human Papilloma Virus Using Sprague-Dawly Models

Human papilloma virus (HPV) causes cervical and many other cancers. Recent trend in vaccine design is shifted toward epitope-based developments that are more specific, safe, and easy to produce. In this study, we predicted eight immunogenic peptides of CD4+ and CD8+ T-lymphocytes (MHC class I and II...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Mehreen, Bai, Baogang, Guo, Jinlei, Bai, Yuhui, Sajid, Zureesha, Muhammad, Syed Aun, Shaikh, Rehan Sadiq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968051/
https://www.ncbi.nlm.nih.gov/pubmed/36838675
http://dx.doi.org/10.3390/molecules28041687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968051/
https://www.ncbi.nlm.nih.gov/pubmed/36838675
http://dx.doi.org/10.3390/molecules28041687

Ejemplares similares